Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sacks

Showing results (181-190 of 283) with videos related to

Pageof 29
Sort By:
Clinical and Experimental Immunology|December 31, 1997
Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient miceN S Sheerin, T Springall, M C Carroll, et al.
Life Sciences|November 11, 1985
Metabolic profiling of radioreceptor-assayable opioid peptides in a human pituitary ACTH-secreting tumorD M Desiderio, R C Cezayirli, G Fridland, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
Contribution of renal secreted complement C3 to the circulating pool in humansS Tang, W Zhou, N S Sheerin, et al.
Archives of Neurology|July 1, 1983
Quantitative CSF IgG measurements in multiple sclerosis and other neurologic diseases. An updateJ T Caroscio, S Kochwa, H Sacks, et al.
Postgraduate Medical Journal|February 11, 2005
Urinary tract infections: new insights into a common problemR Kucheria, P Dasgupta, S H Sacks, et al.
Molecular Immunology|March 4, 2000
Strategies for targeting complement inhibitors in ischaemia/reperfusion injuryJ Dong, J R Pratt, R A Smith, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 10, 2020
l-Fucose prevention of renal ischaemia/reperfusion injury in MiceMark C Howard, Christopher L Nauser, Conrad A Farrar, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 1, 1976
Evaluating signs and symptoms: comparison of structured interview ans clinical approachesW T Carpenter, M H Sacks, J S Strauss, et al.
Kidney International|August 1, 1997
Expression of tissue type plasminogen activator and type 1 plasminogen activator inhibitor, and persistent fibrin deposition in chronic renal allograft failureY Wang, J R Pratt, B Hartley, et al.
Lancet (London, England)|October 31, 1987
Effect of symptomless bacteriuria in childhood on subsequent pregnancyS H Sacks, K Verrier Jones, R Roberts, et al.
Pageof 29

Showing results (181-190 of 283) with videos related to

Sort By:
Pageof 29
Clinical and Experimental Immunology|December 31, 1997
Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient miceN S Sheerin, T Springall, M C Carroll, et al.
Life Sciences|November 11, 1985
Metabolic profiling of radioreceptor-assayable opioid peptides in a human pituitary ACTH-secreting tumorD M Desiderio, R C Cezayirli, G Fridland, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
Contribution of renal secreted complement C3 to the circulating pool in humansS Tang, W Zhou, N S Sheerin, et al.
Archives of Neurology|July 1, 1983
Quantitative CSF IgG measurements in multiple sclerosis and other neurologic diseases. An updateJ T Caroscio, S Kochwa, H Sacks, et al.
Postgraduate Medical Journal|February 11, 2005
Urinary tract infections: new insights into a common problemR Kucheria, P Dasgupta, S H Sacks, et al.
Molecular Immunology|March 4, 2000
Strategies for targeting complement inhibitors in ischaemia/reperfusion injuryJ Dong, J R Pratt, R A Smith, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 10, 2020
l-Fucose prevention of renal ischaemia/reperfusion injury in MiceMark C Howard, Christopher L Nauser, Conrad A Farrar, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 1, 1976
Evaluating signs and symptoms: comparison of structured interview ans clinical approachesW T Carpenter, M H Sacks, J S Strauss, et al.
Kidney International|August 1, 1997
Expression of tissue type plasminogen activator and type 1 plasminogen activator inhibitor, and persistent fibrin deposition in chronic renal allograft failureY Wang, J R Pratt, B Hartley, et al.
Lancet (London, England)|October 31, 1987
Effect of symptomless bacteriuria in childhood on subsequent pregnancyS H Sacks, K Verrier Jones, R Roberts, et al.
Pageof 29